The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
FREE Daily Email Newsletter
Digital Doctors: Medical Professionals Ditch Pen and Paper
May 9, 2013 2:38 pm | Videos | CommentsNew health care laws are urging doctors to keep only digital records, yet only 40 percent of physicians in the U.S. have converted their paper files. To increase those numbers the government subsidizes local experts to help doctors convert.
Dendreon Says Competition Hurt First Quarter Provenge Sales
May 9, 2013 1:54 pm | by The Associated Press | News | CommentsDendreon Corp. said Thursday that sales of its prostate cancer therapy Provenge fell in the first quarter because of increased competition from two newer drugs. Net revenue from Provenge fell 18 percent to $67.6 million, Dendreon said. The company faced tougher competition because regulators...
Health Clinics in Retail Stores a Growing Trend for Patients
May 9, 2013 1:46 pm | by CBS News | Videos | CommentsMore and more Americans are using health clinics inside retail stores instead of going to the doctor or emergency room. Several well-known retailers have clinics in selective stores with about 1,400 open right now. Randall Pinkston reports on why these clinics have become so popular.
Roll-Up Door
May 9, 2013 12:33 pm | Product Releases | CommentsReduced exposure time between differing environments provides less of an opportunity for unwanted insects, birds, dust and other particles to infiltrate a facility. The 6000 Series features a higher speed external jackshaft motor that moves doors at a speed of 36 inches per second.
Multichannel Pipettes
May 9, 2013 12:18 pm | Product Releases | CommentsThe manual Rainin Pipet-Lite XLS+ and electronic Rainin E4 XLS+ offer users durable, lightweight liquid ends and new mechanical designs that all but eliminate hand strain while ensuring the highest channel-to-channel consistency.
Lawsuit Alleges Merck Discriminates Against Women
May 9, 2013 11:48 am | by The Associated Press | News | CommentsA Merck & Co. sales representative is suing the drugmaker for at least $100 million, saying Merck doesn't give women equal opportunities for advancement and punishes employees for taking maternity leave. Kelli Smith, a Merck employee since 2004, says the company's sales plans create...
Nationwide Discrepancy in Hospital Costs
May 9, 2013 8:44 am | Videos | CommentsA new survey has found great discrepancies in the fees hospitals charge for certain procedures. The survey tracked the cost of 100 of the most common procedures and found huge prices differences not only across the country but between nearby facilities. The survey also found that the increased prices did not result in better care.
California Health Exchange Granted Secrecy
May 9, 2013 8:29 am | by MICHAEL R. BLOOD,Associated Press | News | CommentsA California law that created an agency to oversee national health care reforms granted it sweeping authority to conceal spending on the contractors that will perform most of its functions, creating a barrier from public disclosure that stands out nationwide.
Poor Sales of Qsymia Widens Vivus’ First Quarter Losses
May 9, 2013 8:25 am | by The Associated Press | News | CommentsShares of Vivus Inc. plunged in premarket trading Wednesday after the drug developer said it absorbed a $5.8 million charge to write off unsold inventory largely from its initial production of the weight-loss drug Qsymia. The Mountain View, Calif., company started marketing Qsymia last September, after it became the second long-term weight loss drug approved in the United States since 1999.
Orgenesis and ATMI Enter Into Process Development Agreement
May 9, 2013 8:21 am | News | CommentsOrgenesis Inc., a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today that its wholly owned subsidiary, Orgenesis Ltd., has entered into a process development agreement with ATMI, Inc., a global technology company and leader in single-use bioprocess solutions.
Study: Fish Oil Doesn't Help Prevent Heart Attacks
May 9, 2013 8:17 am | by MARILYNN MARCHIONE,AP Chief Medical Writer | News | CommentsEating fish is good for your heart but taking fish oil capsules does not help people at high risk of heart problems who are already taking medicines to prevent them, a large study in Italy found. The work makes clearer who does and does not benefit from taking supplements of omega-3 fatty acids, the good oils found in fish such as salmon, tuna and sardines.
Alexza Pharma Jumps on Adasuve Licensing Deal
May 9, 2013 8:09 am | News | CommentsShares of Alexza Pharmaceuticals Inc. jumped Wednesday after the company said Teva Pharmaceutical Industries Ltd., one of the world's largest drug companies, will market is agitation drug Adasuve in the U.S. The companies said Wednesday that Teva will be responsible for all U.S. commercial and clinical-related activities, including a required post-approval study.
Techulon Awarded $1.9M to Defeat “Superbugs”
May 9, 2013 8:06 am | News | CommentsTechulon, Inc. has been selected by the Defense Advanced Research Projects Agency (DARPA) for a Phase II contract to advance its therapeutic program for multi-drug resistant bacteria, or ‘superbugs.’ This award drives Techulon’s development of a nanotherapeutic agent that will give the Department of Defense and hospitals the ability to rapidly respond and treat patients with life-threatening multi-drug resistant infections.
IMS: US Medicine Spending Shows Rare Dip in 2012
May 9, 2013 8:00 am | by LINDA A. JOHNSON,AP Business Writer | News | CommentsSpending on prescription medicines in the U.S. fell for the first time in decades last year, slipping as cash-strapped consumers continued to cut back on use of health care services. Patients also benefited from a surge of new, inexpensive generic versions of widely used drugs for chronic conditions like high cholesterol, according to a new report.
Drugmakers, Health Groups Bring Poor Girls Vaccine
May 9, 2013 7:58 am | by LINDA A. JOHNSON,AP Business Writer | News | CommentsTwo multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer. Starting with pilot programs in eight Asian and African nations, the ambitious project ultimately is intended to inoculate more than 30 million girls in more than 40 countries by 2020.
